Details for New Drug Application (NDA): 212465
✉ Email this page to a colleague
The generic ingredient in MUPIROCIN is mupirocin. There are sixteen drug master file entries for this compound. Twenty suppliers are listed for this compound. Additional details are available on the mupirocin profile page.
Summary for 212465
Tradename: | MUPIROCIN |
Applicant: | Padagis Israel |
Ingredient: | mupirocin calcium |
Patents: | 0 |
Pharmacology for NDA: 212465
Mechanism of Action | RNA Synthetase Inhibitors |
Suppliers and Packaging for NDA: 212465
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
MUPIROCIN | mupirocin calcium | CREAM;TOPICAL | 212465 | ANDA | Padagis Israel Pharmaceuticals Ltd | 45802-018 | 45802-018-14 | 1 TUBE in 1 CARTON (45802-018-14) / 15 g in 1 TUBE |
MUPIROCIN | mupirocin calcium | CREAM;TOPICAL | 212465 | ANDA | Padagis Israel Pharmaceuticals Ltd | 45802-018 | 45802-018-94 | 1 TUBE in 1 CARTON (45802-018-94) / 30 g in 1 TUBE |
Profile for product number 001
Active Rx/OTC/Discontinued: | DISCN | Dosage: | CREAM;TOPICAL | Strength | EQ 2% BASE | ||||
Approval Date: | Aug 3, 2022 | TE: | RLD: | No |
Complete Access Available with Subscription